Stocktoria

Vicapsys Life Sciences, Inc. VICP

OTC · stock · Pharmaceutical Preparations · website · IPO 2001-07-11

Vicapsys Life Sciences, Inc. (VICP) earns a Piotroski F-score of 1/9 (weak financial health). It does not currently pay a dividend.

1/9
Piotroski F — financial health
Altman Z″ — distress risk
Dividend payout · no dividend
$1.46 as of 2026-06-01 · -17.5% 1y
$1.46$1.7752-wk

Price from month-end closes (Yahoo) — for reference, not real-time.

How it ranks in Manufacturing · percentile among 1906 companies

Piotroski Fstronger than 1%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 1/9 tests passed

Sector peers · similar-size Manufacturing companies

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
VICPVicapsys Life Sciences, Inc.1/9
JNJJOHNSON & JOHNSON4/922.9+6%
LLYELI LILLY & Co7/955.1+44.7%
MRKMerck & Co., Inc.4/917.4+1.3%
PFEPFIZER INC4/917.8-1.6%
ABBVAbbVie Inc.7/9-0.34105.9+8.6%
BMYBRISTOL MYERS SQUIBB CO7/916.7-0.2%

All Manufacturing companies →

FAQ

Is VICP financially healthy?

Vicapsys Life Sciences, Inc.'s Piotroski F-score is 1/9 (8–9 is excellent, 0–3 weak).

Does VICP pay a dividend?

No, Vicapsys Life Sciences, Inc. does not currently pay a dividend.

Source: SEC EDGAR filings · CIK 0001468639 · US · as of 2023-12-31. facts plus Stocktoria's own computed scores — not investment advice.